$2.27
0.05[2.25%]
At close: Apr 25
$2.33
0.0600[2.64%]
After Hours: 8:00AM EDT
Regulus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Regulus Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | RGLS | Q1 | -$0.42 | -$0.21 | — | — | $0.00 | — | — | — | Get Alert |
03/21/2024 | PM | RGLS | Q4 | -$0.40 | -$0.39 | -$0.40 | -2.56% | $0.00 | — | $0.00 | — | Get Alert |
11/09/2023 | PM | RGLS | Q3 | -$0.50 | -$0.40 | -$0.40 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
08/08/2023 | PM | RGLS | Q2 | -$0.50 | -$0.41 | -$0.37 | 9.76% | $0.00 | — | $0.00 | — | Get Alert |
05/11/2023 | PM | RGLS | Q1 | -$0.50 | -$0.44 | -$0.42 | 4.55% | $0.00 | — | $0.00 | — | Get Alert |
03/23/2023 | PM | RGLS | Q4 | -$0.70 | -$0.51 | -$0.40 | 21.57% | $0.00 | — | $0.00 | — | Get Alert |
11/10/2022 | PM | RGLS | Q3 | -$1.00 | -$0.49 | -$0.50 | -2.04% | $0.00 | — | $0.00 | — | Get Alert |
08/11/2022 | PM | RGLS | Q2 | -$0.80 | -$0.50 | -$0.50 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
05/12/2022 | PM | RGLS | Q1 | -$0.80 | -$0.50 | -$0.50 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
03/10/2022 | PM | RGLS | Q4 | -$0.30 | -$0.70 | -$0.70 | 0.00% | $5.00M | — | $0.00 | — | Get Alert |
11/10/2021 | PM | RGLS | Q3 | -$0.40 | -$0.80 | -$1.00 | -25.00% | $5.00M | — | $0.00 | — | Get Alert |
08/10/2021 | PM | RGLS | Q2 | -$2.30 | -$0.80 | -$0.80 | 0.00% | $0.00 | $10.00K | $0.00 | -100.00% | Get Alert |
05/13/2021 | PM | RGLS | Q1 | -$2.50 | -$0.90 | -$0.80 | 11.11% | $6.00K | $20.00K | $0.00 | -100.00% | Get Alert |
03/09/2021 | PM | RGLS | Q4 | -$2.30 | — | -$0.30 | — | $18.00K | — | $5.00M | — | Get Alert |
11/05/2020 | PM | RGLS | Q3 | -$2.60 | -$2.10 | -$0.40 | 80.95% | $18.00K | $340.00K | $5.00M | 1370.59% | Get Alert |
08/13/2020 | PM | RGLS | Q2 | -$3.00 | — | -$2.30 | — | $18.00K | — | $0.00 | — | Get Alert |
05/14/2020 | PM | RGLS | Q1 | -$3.10 | — | -$2.50 | — | $6.78M | — | $6.00K | — | Get Alert |
03/12/2020 | PM | RGLS | Q4 | -$9.80 | — | -$2.30 | — | $18.00K | — | $18.00K | — | Get Alert |
11/12/2019 | PM | RGLS | Q3 | -$11.80 | — | -$2.60 | — | $18.00K | — | $18.00K | — | Get Alert |
Regulus Therapeutics (RGLS) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 21, 2024 for Q4.
The Actual EPS was $-0.40, which missed the estimate of $-0.39.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.